Is CBOP/BEP an Alternative to BEP for Patients With Poor Prognosis Metastatic Germ Cell Tumours?

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2016-000089
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Accelerated BEP: A Phase I Trial of Dose-Dense BEP for Intermediate and Poor Prognosis Metastatic Germ Cell Tumour

British Journal of Cancer
Cancer ResearchOncology
2011English

Protocol for the P3BEP Trial (ANZUP 1302): An International Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Adult and Paediatric Male and Female Patients With Intermediate and Poor-Risk Metastatic Germ Cell Tumours

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Adjuvant Therapy for Stage IB Germ Cell Tumors: One Versus Two Cycles of BEP

Advances in Urology
GynecologyUrologyObstetrics
2018English

Long-Term Outcome in Patients With Germ Cell Tumours Treated With POMB/ACE Chemotherapy: Comparison of Commonly Used Classification Systems of Good and Poor Prognosis

British Journal of Cancer
Cancer ResearchOncology
1989English

MGMT and CALCA Promoter Methylation Are Associated With Poor Prognosis in Testicular Germ Cell Tumor Patients

Oncotarget
Oncology
2016English

Beta-1,4-Galactosyltransferase II Predicts Poor Prognosis of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma

Tumor Biology
MedicineCancer Research
2017English

CXCL12 Expression Is an Adverse Predictor for Disease Recurrence in Patients With Metastatic Non-Seminomatous Testicular Germ Cell Tumors

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Application of the International Germ Cell Consensus Classification to the Nova Scotia Population of Patients With Germ Cell Tumours

Canadian Urological Association Journal
Urology
2013English

LINK‑A lncRNA Is Upregulated in Metastatic Non‑small Cell Lung Cancer and Is Associated With Poor Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy